NASDAQ · SHCR
Sharecare, Inc.
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
NYSE · RAD · USD
Stock price, dividends, earnings
Quote as of Oct 13, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Rite Aid Corporation’s quoted price sits in the lower half of its reported 52-week range, 91.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Rite Aid Corporation’s forward annual dividend is $9.20 per share, paid quarterly. The forward yield is 1,419.1% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Rite Aid Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Rite Aid Corporation, through its various subsidiaries, manages an extensive network of retail pharmacies across the United States. The company's business activities are structured into two main divisions: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing prescription drugs and delivers a wide array of supplementary pharmacy and wellness services. These include administering key immunizations such as those for COVID-19, influenza, and shingles, along with providing assistance to customers managing conditions like hypertension, high cholesterol, and diabetes. It also offers advice on weight loss and quitting smoking, and educates patients on their medications and potential adverse effects. Beyond pharmaceutical care, this segment stocks a broad assortment of consumer goods, including over-the-counter medicines, personal care products, cosmetics, health and beauty aids, seasonal items, household essentials, food, beverages, greeting cards, general merchandise, and pet supplies, complemented by its own private brand line. Furthermore, it operates retail clinics and offers specialized healthcare coaching and disease management solutions to health plans and employers. In contrast, the Pharmacy Services segment provides a complete package of integrated pharmacy benefit management (PBM) offerings. These solutions comprise advanced technology systems, mail-order drug delivery, specialty pharmacy services for complex conditions, efficient network and rebate administration, claims processing, and various pharmacy discount initiatives. This segment is also responsible for managing prescription drug benefits under the federal Medicare Part D program and offering insurance plans to individuals and diverse institutional clients, such as health plans, commercial businesses, labor unions, and governmental entities at state and local levels. As of February 26, 2022, Rite Aid operated 2,450 retail pharmacy outlets spread across 17 states. Established in 1962, the corporation is headquartered in Philadelphia, Pennsylvania.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2022 | Apr 14, 2022 | -$1.63-185.96% vs estimate | $6.07B+5.49% vs estimate |
|---|
| Q3 2022 | Dec 21, 2021 | $0.15+183.33% vs estimate | $6.23B+4.77% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
10 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
CHF 1.02-CHF 0.05 (-4.67%)
SHL Telemedicine Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
$7.56+$0.29 (+3.99%)
Eyenovia, Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.94% below the high.
$4.34$0.00 (0.0%)
Lumos Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.15% below the high.
$1.10$0.00 (0.0%)
Satsuma Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.39% below the high.
$5.75+$0.02 (+0.35%)
Science 37 Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.63% below the high.
$0.43+$0.00 (+0.25%)
Akili, Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.35% below the high.
$0.04$0.00 (0.0%)
Telesis Bio, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.27% below the high.
